TNF and breast cancer: These data fueled our initial hypothesis that using clinically available TNF-α inhibitors would be a smart approach to alter the secretion profile of invasive breast cancer cells, and thus motivated us to assess the inhibitory effect of Etanercept, a TNF-α inhibitor, to suppress proliferation and survival of breast cancer cells.